Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Filings indexed 2,580 across all filing types
Latest filing 2015-07-02 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring. It mentions stock suspension due to the ongoing major asset reorganization, ongoing communication and due diligence, and promises to update every five trading days. The document is short (619 characters) and is an update on the status of a major asset reorganization, not a full report or financial statement. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2015-07-02 Chinese
关于下属子公司收到政府补助资金的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about government subsidies received by its subsidiaries, detailing amounts, dates, and accounting treatment. It is a regulatory announcement about financial matters but does not contain comprehensive financial statements or detailed financial performance data. The document is relatively short (2315 characters) and serves as an official disclosure of government grants received, not a full financial report or audit. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into other specific categories like Annual Report, Interim Report, or Earnings Release.
2015-07-02 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring. It mentions stock suspension due to the ongoing asset reorganization, ongoing communication with related parties, and periodic updates every five trading days. The document does not contain financial statements or detailed financial data but is an update on a corporate transaction process. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2015-06-25 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring. It mentions stock suspension due to the ongoing asset reorganization and states that the company will continue to disclose updates every five trading days. The content focuses on the status and procedural updates of a significant corporate transaction rather than the transaction completion or detailed merger documents. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is short and does not contain financial statements or detailed reports, so it is not an Annual Report or Interim Report. It is not a regulatory filing or announcement of a report publication. Therefore, the best classification is CAP with high confidence.
2015-06-17 Chinese
关于子公司基因科技有限公司对外投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 中源协和细胞基因工程股份有限公司 regarding its subsidiary's external investment to establish a new company. It details the investment amount, purpose, board approval, and potential risks. There are no financial statements, quarterly or annual results, or audit information. The document is a formal announcement about a capital investment activity by the subsidiary, not a report or financial filing. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and contains substantive information about the investment, not just a notice or report publication announcement.
2015-06-15 Chinese
重大资产重组继续停牌公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the continuation of a trading suspension due to an ongoing major asset restructuring. It details the progress of the restructuring, the parties involved, and the reasons for the continued suspension of trading. The document does not contain financial statements or detailed financial analysis but is an update on a capital restructuring event. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes. The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2015-06-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.